Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Hemab Therapeutics Holdings, Inc. - Common Stock (NQ:COAG)

26.57 +1.02 (+3.99%)
Streaming Delayed Price Updated: 2:27 PM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hemab Therapeutics Holdings, Inc. - Common Stock

News headline image
Hemab Therapeutics Details Post-IPO Pipeline Push, Sutacimig Phase III Plans ↗
Hemab Therapeutics (NASDAQ:COAG) Chief Executive Officer Benny Sorensen outlined the company’s development plans following its recent initial public offering during a fireside chat with Jefferies... 
Via MarketBeat
News headline image
Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
From Hemab Therapeutics, Inc.
Via GlobeNewswire
News headline image
Hemab Therapeutics Reports First Quarter 2026 Financial Results
From Hemab Therapeutics, Inc.
Via GlobeNewswire
News headline image
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Hemab Therapeutics, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.